|Articles|August 14, 2012

Individualized therapy - The modern standard in wet AMD care

Novartis sponsored a symposium at the COPHy congress in 2012 exploring the current treatment issues surrounding wet AMD. This supplement reveals the highlights of the meeting.

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Subscribe

Related Content

(Ophthalmology Times Europe) Lab bench to bedside to backpack: AI’s reach in retinal disease

AI's reach in retinal disease: Lab bench to bedside to backpack

BySheryl Stevenson

September 7th 2026

Effect of a maternal high-fat diet on the peripheral retina in mice

ByLynda Charters

August 12th 2026

Real-World Outcomes of a Spiral Optic IOL Compared with a Diffractive Trifocal

ByJames Myerscough, MD

August 1st 2026

Necessity-Driven Innovation - A Personal Journey Toward Efficient and Controlled 27-Gauge Vitrectomy

ByMitrofanis Pavlidis, MD, PhD

August 1st 2026

Functional OCT takes retinal imaging where structure alone cannot go

ByAnat Loewenstein, MD, MHA,Sheryl Stevenson

July 25th 2026

Latest CME

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Individualized therapy - The modern standard in wet AMD care

Related Content

AI's reach in retinal disease: Lab bench to bedside to backpack

Effect of a maternal high-fat diet on the peripheral retina in mice

Real-World Outcomes of a Spiral Optic IOL Compared with a Diffractive Trifocal

Necessity-Driven Innovation - A Personal Journey Toward Efficient and Controlled 27-Gauge Vitrectomy

Functional OCT takes retinal imaging where structure alone cannot go

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD